جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

ملخص مؤتمروصول مفتوح2026

Diagnostic Accuracy of Modalities For Acute Heart Failure In Emergency Settings. A Systematic Review and Diagnostic Accuracy Meta-Analysis

Saudi Journal of Emergency Medicine · مجلد 7 (1S) · 91-91

Background: Acute heart failure diagnosis in emergency departments remains challenging despite multiple available diagnostic modalities. Current emergency evaluations rely variably on clinical assessment, biomarkers, and ultrasound techniques; however, their comparative diagnostic accuracy remains inadequately compared in previous studies. This systematic review and meta-analysis aim to evaluate the diagnostic accuracy of four categories of diagnostic approaches: Clinical Assessment, Biomarker Assessment, Basic Ultrasound Assessment, and Advanced Ultrasound Assessment for diagnosing acute heart failure in emergency settings. Methods: We conducted a literature review across PubMed/MEDLINE, Scopus, Google Scholar, Cochrane Library, Google Scholar, and Web of Science up to December 2024. Studies investigating the diagnostic modalities for acute heart failure in emergency settings with sufficient data to construct 2×2 contingency tables were included. Two independent reviewers performed screening, data extraction, and quality assessment using QUADAS-2. Diagnostic accuracy was synthesized using a bivariate random-effects model. Summary receiver operating characteristic (SROC) curves, pooled sensitivity, specificity, and area under the curve (AUC) were calculated with 95% confidence intervals (CI). Heterogeneity was assessed using I² statistics and publication bias with Deeks' funnel plot. Results: Thirty-three studies including a total of 17 participants to 1,586 participants met the inclusion criteria. Clinical Assessment demonstrated moderate diagnostic performance (AUC=0.591) with limited sensitivity (0.500, 95% CI: 0.484-0.515) but high specificity (0.858, 95% CI: 0.830-0.886). Biomarker Assessment showed excellent performance (AUC=0.906) with high sensitivity (0.874, 95% CI: 0.872-0.875) and good specificity (0.781, 95% CI: 0.778-0.783). Basic Ultrasound Assessment had moderate performance (AUC=0.750) with low sensitivity (0.349, 95% CI: 0.303-0.395) but high specificity (0.889, 95% CI: 0.874-0.904). Advanced Ultrasound Assessment demonstrated excellent performance (AUC=0.892) with good sensitivity (0.713, 95% CI: 0.705-0.720) and very high specificity (0.903, 95% CI: 0.900-0.905). All modalities showed remarkably consistent performance across studies (I²=0%). Conclusion: Biomarker Assessment provides the highest overall diagnostic accuracy for acute heart failure in emergency settings, while Advanced Ultrasound Assessment offers the optimal balance between sensitivity and specificity when equipment and expertise are available. Clinical Assessment alone has limitations for detecting acute heart failure but remains useful for exclusion. Our findings highly recommend adapting a multimodal diagnostic approach integrating biomarkers and advanced ultrasound techniques whenever possible for optimal diagnostic accuracy in emergency settings.

acute heart failureemergency diagnosisdiagnostic accuracyclinical evaluation
ملخص مؤتمروصول مغلق2025

Evaluation of red blood cell exchange practices in the management of sickle cell disease across gulf region hospitals

Blood · مجلد 146 (Supplement 1) · 6689-6689

Abstract Introduction Red blood cell exchange (RBCX) has become a keytherapeutic modalityin managingpatients with sickle cell disease (SCD), enabling the removal of abnormalerythrocytesandimprovingclinical outcomes.Automated exchange offers betterHbScontrol, less iron overload, and greater efficiencyparticularlyin high-volumesettings. SCD is a significant public health concern in many Gulf countries due to high carrier prevalence and consanguineous marriage patterns.Thisstudy aims to evaluate current RBCX practices in selected hospitals across the Gulf region, focusing on both elective and emergency exchange procedures, as well as their clinical indications. Methods A cross-sectional study was conducted between January and April 2025 to evaluate red blood cell exchange practices in the management of sickle cell disease across the Gulf region. The questionnaire was distributed via WhatsApp to healthcare professionals in Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Oman, and Qatar. A structured survey was developed, reviewed, validated, and distributed to capture data related to the availability of RBCX, procedure types (manual vs. automated), frequency, clinical settings, institutional guidelines, team roles, and barriers to implementation. Respondents were not limited to specific hospitals; responses were based on individuals who voluntarily participated. Although the survey was circulated broadly, responses were mostly concentrated in Saudi Arabia, and some countries were not represented in the final dataset. Results A total of 94 healthcare professionals from 53 hospitals participated across the Gulf region. Of these, 86 (91.5%) were from Saudi Arabia, and 8 (8.5%) were from other cities within the Gulf region. The survey included responses from both adult and pediatric institutions, reflecting wide spectrum of RBCX paractices. Among the respondents, 88 (93.6%) reported that red blood cell exchange (RBCX) is performed at their institutions. Of these, 29 (33%) relied on manual exchange, 25 (28.4%) employed automated exchange, and 34 (38.6%) utilized both methods. Regarding procedural frequency, 41 respondents (46.6%) reported performing 5 to 15 RBCX procedures per month, 35 (39.8%) reported fewer than 5 procedures, and 12 (13.6%) reported more than 15 procedures per month. Emergency RBCX was most commonly performed in intensive care units (90.9%), followed by wards (40.9%), high dependency units (23.9%), and emergency rooms (10.2%). Elective procedures were primarily conducted in day care units (40.9%), intensive care units under regular admission (30.7%), and inpatient wards (26.1%). Institutional guidelines for RBC exchange in sickle cell disease were reported by 63 participants (71.6%), while 25 (28.4%) lacked standardized protocols. Among the six centers not offering RBCX, the main barriers included insufficient resources (66.7%), lack of institutional support (66.7%), unclear processes or guidelines (50%), and limited staff experience (16.7%). Additionally, role clarity was reported by 78 respondents (88.6%), with physicians overseeing initiation and clinical decisions, nurses managing patient preparation and monitoring, and laboratory staff handling machine operation and blood coordination. Conclusion Red blood cell exchange is widely practiced for the management of sickle cell disease across responding institutions in the Gulf region, with substantial variation in procedural types, clinical settings, and institutional readiness. Expanding access to automated RBCX in high-volume and tertiary care settings may improve patient outcomes and reduce transfusion-related complications. To achieve this, health systems must address barriers such as limited resources, staffing shortages, and the lack of clear institutional guidelines. These findings support the need for regional collaboration and the development of standardized protocols to optimize care quality and clinical outcomes for patients with sickle cell disease. Although our survey did not directly assess long-term monitoring practices or program structures, previous literature has highlighted the benefits of outpatient RBCX programs and the importance of tracking outcomes such as HbS levels, transfusion-related reactions, and iron overload. These areas represent future opportunities for clinical improvement and system-level quality initiatives.

red blood cell exchangesickle cell diseaseindicationstransfusion guidelines
ملخص مؤتمروصول مغلق2019

Trauma Certification and Hospital Referral Region Diversity: A System Approach Theory

Academy of Management Proceedings · مجلد 2019 (1) · 11608-11608

The U.S. model for trauma care has been seen as one of the most advanced systems in the world, however, there are clear racial and ethnic disparities in the trauma care service delivery that warrant further investigation. Previous inquiry has indicated that the prevalence of trauma centers (TCs) may be related to environmental factors, and differences in health utilization. However, previous inquiry has not examined the possible relationships between structural determinants that relate to the level of trauma care designations (L-I through L-IV) or verification along with social factors of the surrounding community as it relates to its population of diversity. Thus, this study is focused on examining the relationship between community diversity in a Hospital Referral Region (HRR), and U.S.-based hospitals’ attainment of trauma certification and trauma designation L-I/II. We conducted a cross-sectional analysis of data from the 2017 American Hospital Association (AHA) Annual Survey, Current Population Survey (CPS) , and the Dartmouth Atlas Hospital Referral Region datasets. Poisson regression and propensity score matching were used to analyze 303 HRRs. Our primary dependent variables were hospitals with trauma certification and hospitals with trauma L-I/II. Our primary independent variable was the diversity of an HRR operationalized by estimating an entropy index score for each county–aggregated to the HRR level–that is comprised of the proportions of the ethnic groups. We found that hospitals with trauma certification or trauma L-I/II were more likely to be in HRRs with less diverse population. Furthermore, market competition was a significant factor in reducing the availability of trauma certified centers. Our findings highlight that in the U.S. system disparities do exist in trauma care. Research is needed to determine if other factors such as resource allocation and reimbursements distribution from Medicaid Disproportionate Share Hospital have impact the availability of trauma facilities.

trauma centershospital referral regionsracial and ethnic disparitiescommunity diversity
ملخص مؤتمروصول مغلق20181استشهاد· Semantic Scholar

A Clinical, Genomic and Proteomic Approach for the Characterization of Fanconi Anemia in Adolescent and Young Adult (AYA) Patients : A Single Center Study of 55 Patients from a National Bone Marrow Failure Referral Center

Blood · مجلد 132 (Supplement 1) · 2594-2594

Abstract Introduction: Fanconi Anemia (FA) is an autosomal recessive disorder characterized by bone marrow failure (BMF), constitutional anomalies and high risk of developing cancer. Distinguishing FA from severe aplastic anemia (SAA) can be challenging especially in asyndromic patients. We undertook a clinical and laboratory cohort study of adolescent and young adult (AYA) patients with a diagnosis of FA treated at our institution to characterize the clinical features in our population, and conducted a prospective translational study to explore integration of a genomic and proteomic approach for improved diagnosis and molecular characterization of FA. Methods: Data on FA patients was obtained from an institutionally approved BMF database and hematopoietic stem cell transplant (HSCT) database. Further data was obtained from a register of chromosomal breakage (CB) analysis results. Index cases were identified if they were older than 14 years of age at the time of diagnosis or under the care of adult hematology with a clinical diagnosis of FA based on the presence of BMF and abnormal CB, or clinical phenotype with the presence of homozygous FA related genes. Family pedigrees were constructed based on history. In addition, patients presenting with BMF were enrolled onto an institutionally approved study investigating proteomic biomarkers and genomics of BMF syndromes. Consented peripheral blood samples and/or extracted DNA were subject to either panel based next generation sequencing (NGS) testing as part of the Saudi Genome Project or subjected to whole exome sequencing (WES) by external lab. For proteomic analysis, peripheral blood plasma (PBP) samples from 6 patients with FA, 10 SAA patients and 7 normal controls were subjected to expression proteomics using liquid chromatography tandem mass spectrometry (LC-MS/MS). Result: Patients and clinical features: 55 patients (26 M, 29 F) in 30 families were identified. While 18 patients (32%) were referred with a diagnosis/suspicion of FA, in 26 (47%) FA was diagnosed at our institution. The most frequent anomaly was short stature (14 patients, 25%), skin changes (7, 12%), urogenital abnormalities (7, 12%), dysmorphism/craniofacial abnormalities (7, 12%), hands anomalies (4, 7%); 12 (22%) had no recorded anomalies. 18 patients (33%) developed a malignancy either before or after diagnosis of FA: solid tumors in 5 (9%), AML and/or MDS in 15 (27%); 3 (5%) of these patients had both solid tumors and AML/MDS. Diagnostic Tests: 35 patients (63.6%) had a positive CB analysis with diepoxybutane (DEB) or mitomycin-C (MMC) testing; in 5 patients (9%) DEB testing was borderline and 3 (5%) had a normal CBA but had a diagnostic phenotype+/- family history and presence of a homozygous mutation in a known FA related gene. 14 patients had cytogenetic abnormalities and abnormalities involving chromosome 1 were the most frequent (50%). Mutation Analysis: Mutational analysis was available for 12 (22%) cases; homozygous mutations in FA genes were identified in 10 patients (18%) in 7 families (23% of families): FANCA (5 patients/3 families); BRIP1 (2/2); FANCP (1/1); FANCD2 (2/1). In one case, post matched sibling (HSCT) blood sample revealed a known pathogenic heterozygous c.2632G>C,p.Glu878Gln mutation in FANCA, suggesting a carrier donor. Proteomic analysis: Over 1650 unique PBP protein species were identified of which 605 were significantly differentially expressed (≥ 2 to ∞ - fold change & p < 0.001) between SAA /FA/ normal control subjects (Fig 1a). DNMT3A, Kinase Insert Domain Receptor (KDR) and TGFB-1 was found to be highly expressed in SAA versus FA, while ATM and APOB were highly expressed in FA versus SAA (Fig.1b). Treatment outcomes: 36 out of 55 patients (65%) received HSCT. Actuarial survival of HSCT (n=37) and non-HSCT (n=14) patients was 70% and 77%, respectively. Treatment details were not available on 6 (11%). CONCLUSION: We report the first characterization of AYA patients with FA in Saudi Arabia. Our report emphasizes the need for a high index of suspicion of a diagnosis of FA in BMFs. CB may be falsely negative in cases, and panel based and/or WES based NGS testing increases diagnostic accuracy; in this cohort, mutations in FANCA were the most frequent (50%). Occurrence of hematological and solid tumors is a significant risk in these AYA patients. We also report proteomic panels as potential biomarkers that distinguish FA from SAA and may provide mechanistic insights. Disclosures No relevant conflicts of interest to declare.

Fanconi anemiabone marrow failureadolescent and young adult patientssevere aplastic anemia
ملخص مؤتمروصول مغلق2015

The flavonoid, rutin, ameliorates neurodegeneration in the retina of diabetic rats (CAM1P.164)

The Journal of Immunology · مجلد 194 (1_Supplement) · 48.21-48.21

Abstract Diabetic retinopathy remains the leading cause of blindness worldwide. Dietary flavonoid, rutin may protect the diabetes induced retinal damage. The purpose of this study was to examine the ameliorative effect of rutin on diabetic rat retina through neurotrophic, inflammatory and immunological parameters. Diabetes was induced in male Wistar rats by streptozotocin (65mg/kg). Rutin (100mg/kg) was orally administered to normal and diabetic rats after two weeks of diabetes induction and continued for five weeks. After treatments, retinas were isolated and analyzed for potential neuroinflammatory and immunological markers. Our results indicate that the reduced level of brain derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the diabetic retina were significantly improved by rutin. Increased levels of soluble intracellular adhesion molecule (sICAM-1) and monocyte chemotactic protein (MCP-1) in the diabetic retinas were significantly attenuated to normal level by rutin. Reduced level of GSH in diabetic retina was increased and the increased level of TBARS in the diabetic retina was significantly decreased by rutin administration. The increased level of caspase-3, and decreased level of Bcl-2 in diabetic retina were significantly ameliorated to normal levels by rutin. These results suggest the effectiveness of rutin in protection of diabetic induced damage to the retina by maintaining neurotrophic support, and antioxidants levels.

rutinflavonoidsdiabetic retinopathyneurodegeneration